TAHLOBRY Trademark

Trademark Overview


On Tuesday, October 21, 2025, a trademark application was filed for TAHLOBRY with the United States Patent and Trademark Office. The USPTO has given the TAHLOBRY trademark a serial number of 99454077. The federal status of this trademark filing is REGISTERED as of Tuesday, May 5, 2026. This trademark is owned by Merck Sharp & Dohme B.V.. The TAHLOBRY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
tahlobry

General Information


Serial Number99454077
Word MarkTAHLOBRY
Filing DateTuesday, October 21, 2025
Status700 - REGISTERED
Status DateTuesday, May 5, 2026
Registration Number8242661
Registration DateTuesday, May 5, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 17, 2026

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 21, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerck Sharp & Dohme B.V.
Party Type30 - Original Registrant
Legal Entity Type26 - NOT AVAILABLE
AddressHaarlem 2031BN
NL

Party NameMerck Sharp & Dohme B.V.
Party Type20 - Owner at Publication
Legal Entity Type26 - NOT AVAILABLE
AddressHaarlem 2031BN
NL

Party NameMerck Sharp & Dohme B.V.
Party Type10 - Original Applicant
Legal Entity Type26 - NOT AVAILABLE
AddressHaarlem 2031BN
NL

Trademark Events


Event DateEvent Description
Tuesday, October 21, 2025NEW APPLICATION ENTERED
Tuesday, October 21, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, October 21, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 8, 2026ASSIGNED TO EXAMINER
Wednesday, January 21, 2026SUSPENSION LETTER WRITTEN
Wednesday, January 21, 2026LETTER OF SUSPENSION E-MAILED
Wednesday, January 21, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 9, 2026TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, February 9, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 9, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 23, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 11, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 17, 2026PUBLISHED FOR OPPOSITION
Tuesday, March 17, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, May 5, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED